Medtronic Banking On Gene Therapy For Drug-Coated Stents With AVI Deal
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's drug-coated stent development program is using an unapproved antisense compound, Resten-NG, licensed from AVI BioPharma.